Solving Robust Glucose-Insulin Control by Dixon Resultant Computations by Kovács, Laura et al.
Solving Robust Glucose-Insulin Control by Dixon Resultant Computations
Laura Kova´cs
TU Vienna
Austria
lkovacs@complang.tuwien.ac.at
Be´la Pala´ncz
Budapest University of
Technology and Economics
Hungary
palancz@epito.bme.hu
Levente Kova´cs
Budapest University of
Technology and Economics
Hungary
lkovacs@iit.bme.hu
Abstract—We present a symbolic approach towards solving
the Bergman three-state minimal patient model of glucose
metabolism. Our work first translates the Bergman three-
state minimal patient model into the modified control algebraic
Riccati equation. Next, the modified control algebraic Ricatti
equation is reduced to a system of polynomial equations, and
an optimal (minimal) solution of these polynomials is computed
using Dixon resultants. We demonstrate the use of our method
by reporting on three case studies over glucose metabolism.
Keywords-control engineering, glucose-insulin control, mini-
max optimization, polynomial equations, Dixon resultants
I. INTRODUCTION
According to the data provided by the World Health
Organization (WHO), diabetes mellitus is predicted to be
the “disease of the future” especially in the developing
countries [1]. The diabetic population, representing 4% of
the world’s population in the year 2000, is predicted to be
doubled by the year 2030 and is being estimated to be 5,4%
of the world’s total population. The recent statistics of [2]
show the same prevalence in terms of the period between
years 2010-2030, and report on a significant increase in the
overall diabetes population; for example 6.4% of the world’s
population in the year 2010 and an estimate of 7.7% in the
year 2030.
Understanding and preventing the risks emphasized by
these statistics requires a better understanding of the diabetes
characteristics of a human body. It is well-known that the
normal blood glucose concentration level in the human body
varies in a narrow range, between 70 - 110 ml/dL. If for
some reasons the human body is unable to control the
normal glucose-insulin interaction, for example the glucose
concentration level is constantly out of the aforementioned
range, diabetes mellitus, or simply just diabetes, is diag-
nosed. Depending on the blood glucose concentration level,
diabetes is classified in various types, such as: (i) type I, also
known as insulin dependent diabetes mellitus or IDDM; (ii)
type II, also known as insulin independent diabetes mellitus
or NIDDM; (iii) gestational diabetes (under pregnancy);
and (iv) caused by genetic deflections. The consequences
of diabetes are known to be mostly long-term; among
others, diabetes increases the risk of cardiovascular diseases,
neuropathy, and retinopathy [3].
Among the existing types of diabetes, we focus in this
paper on type I diabetes mellitus. This type of diabetes
is determined by the loss of insulin producing beta-cells,
since they are completely destroyed by a still unknown au-
toimmune process [3]. Therefore, there is no human insulin
production and an external insulin source has to be applied.
For this reason, the question of artificial pancreas appeared
and has been addressed throughout the past decades in order
to enable the automatic control and treatment of diabetes
mellitus [4], [5], [6].
The approach of a systematic artificial pancreas is to
formulate the partially or totally deficient blood glucose
control system of the human body as an engineering prob-
lem. To this end, from an engineering point of view, the
treatment of diabetes mellitus can be represented by an outer
control loop. As pointed out in [4], [5], the difficulty with
engineering artificial pancreas comes with the design of (i) a
continuous glucose sensor for measurements, (ii) an insulin
pump for infusion, and (iii) a control algorithm. Moreover,
an appropriate control algorithm crucially depends on the
underlining computational model. For this reason, different
mathematical models of the human blood glucose system
have appeared during the last decades – see [6] for a brief
overview.
The nonlinear model described in [7] proved to be
the simplest one and was developed for type I diabetes
patients under intensive care. However, its simplicity is
also its disadvantage since in its formulation many com-
ponents of the glucose-insulin interaction were neglected.
Therefore, more general, but more complicated nonlinear
models appeared, e.g. [8], [9], [10], [11], [12], where the
nonlinear behavior of these models encode specific control
aspects, such as stability, controllability, and observability.
Consequently, control strategies for modeling the blood-
glucose problem have been widely studied in the literature,
e.g. [4], [5], [6]. Predictive or adaptive control proved to
give adequate results if individualized treatment is desired.
However, general requirements, like avoiding hypoglycemia
(deviation under the basal glucose level) and minimizing
hyperglycemia (deviation over the basal glucose level) are
non-individual dependent ”constraints”, and these cannot
be generally guaranteed by the aforecited control methods.
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Modern robust control methods are capable to handle such
problems by designing optimal controllers on hard con-
straints [13], searching to determine the worst case of the
system and determining an optimal solution for this case;
hence, by designing a robust controller. Different methods
are known in this topic, for example the H2/H∞ method,
also known as extended Linear Quadratic (LQ) method or
minimax method; the pure H∞ method; or the μ-synthesis
method [13]. A detailed comparison and study of these
methods in the modern robust control of the blood glucose
system can be found in [14], [15].
However, all aforementioned methods are applicable effi-
ciently only for linear models. Hence, to use these methods,
the nonlinear models should be first linearized. Nonlinearity
is however in general unavoidable in the proper mathe-
matical modeling of artificial pancreas. Therefore, control
methods developed directly for nonlinear systems are needed
[16].
In [17] a differential geometric approach is proposed,
combining advantages of linear-model based control theory,
but it comes at the cost of high computational complexities
of deployed numeric operations. The works described in
[18], [19] overcome the difficulties of numeric computations
and propose the use of formal methods, such as symbolic
computation [20] and model checking [21], in the study of
biological control systems. The control properties studied
in [18] are expressed using temporal logic and describe
changes between various states of the control model of a
biological process. The formal analysis of these properties
is then performed using symbolic model checking [21].
Characterizing the relation between the control states of
a biological process is also addressed in [19]. However,
unlike [18], the approach of [19] describes the nonlinear
model as a collection of polynomial equations, and uses
Gro¨bner basis computation [22] for solving the polynomial
constraints. While the technique of [19] makes the first
steps towards using symbolic computation in the artificial
pancreas problem by deploying the Bergman-minimal model
[7] and the H2/H∞ method, it faces a number or practical
challenges. To name a few, the polynomial constraints of the
control model contains a large number of variables, and the
initial states of the models are in general unknown.
In this paper we address these challenges and propose
the use of Dixon resultants [23], for studying the diabetic
system of glucose metabolism (Section IV). While glucose
metabolism can be modeled in different ways, we make
use of the Bergman three-state minimal patient model (Sec-
tion II) for the following reasons. This model can be found in
the background of any other model of glucose metabolism,
and it can be used in conjunction with symbolic techniques
for solving polynomial constraints, such as Gro¨bner basis
computations or Dixon resultants. In our approach to solve
the Bergman three-state minimal patient model, we first
reduce the model to the modified control algebraic Riccati
equation (MCARE) and then propose a method to symbol-
ically solve the optimal solution of MCARE (Section III).
Our solution uses the computation of Dixon resultant, and
therefore benefits from the relatively small size of Dixon
resultants (Section IV). Further, as Dixon resultants allow
the elimination of more than one variable in one step
of a computation, solving multivariate polynomial systems
can become more efficient by using Dixon resultants. We
demonstrate the use of our method by various case studies
over glucose metabolism (Section V). All computations
described in this paper were carried out using the symbolic
computation framework of the computer algebra system
Mathematica [24].
II. PRELIMINARIES
This section contains some definitions and properties
about polynomials and matrixes (Section II-A), which are
used in the rest of the paper. For additional details we
refer to [25]. Next, we overview the Bergman three-state
minimal patient control model of [7] (Section II-B), and
present how this nonlinear control model can be linearized
(Section II-C). Finally, the minimax method [13] is briefly
introduced (Section II-D).
A. Algebraic Considerations
Throughout this paper we write Q and C to mean,
respectively, the set of rational and complex numbers. For a
complex number z ∈ C, we denote by Real(z) and Im(z)
its real part, respectively its imaginary part.
In the sequel, let K denote an arbitrary field of char-
acteristic zero (e.g. Q, C, etc.). For variables x1, . . . , xm,
with m ≥ 1, the ring K[x1, . . . , xm] denotes the ring of
polynomials in variables x1, . . . , xm with coefficients in
K. A polynomial p(x1, . . . , xm) ∈ K[x1, . . . , xm] is called
symmetric if, after interchanging any of its variables, one
obtains the same polynomial p(x1, . . . , xm). A polynomial
equation is p(x1, . . . , xm) = 0. Throughout this paper
whenever we refer to a solution or a root of p(x1, . . . , xm)
we mean values of x1, . . . , xm such that p(x1, . . . , xm) = 0.
Given an n × m matrix A, we write by AT the m × n
matrix denoting the transpose of A. A is a square matrix if
n = m. Further, a square matrix A is called symmetric if
A = AT . Let x = (x1, . . . , xm) denote a nonzero complex
vector. An m×m square matrix A with complex coefficients
is a positive definite matrix if Real
(
xTAx
)
> 0.
B. The Bergman Three-State Minimal Patient Control Model
In what follows, we use the following measures: mg for
milligrams, mU for milliUnits, min for minutes and dL for
deciliters.
According to [7], the three-state minimal patient control
model of glucose metabolism is characterized by the fol-
lowing three state variables (represented as functions over
rationals with values in rationals): (i) G(t) denoting the
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plasma glucose deviation measured in mg/dL, (ii) X(t)
representing the remote compartment insulin utilization mea-
sured in 1/min, and (iii) Y (t) denoting the plasma insulin
deviation measured in mU/dL. The behavior of these state
variables is characterized by the physical parameters as well
as by the model parameters of the model. By physical
parameters we mean the basal glucose level (denoted by GB
and measured in mg/dL), the basal insulin level (denoted by
Y B and measured in mU/dL), and the insulin distribution
volume (denoted by V L and measured in dL) in the model.
In the sequel, the model parameters of the model will be
denoted by p1, p2, p3, and p4, where p1, p2, p4 represent
measures in 1/min and p3 is dL/(mU ∗min
2). The value
of the physical and model parameters are given by [26].
However, to avoid round-off errors in representing these
parameters, we consider the physical and model parameter
to be rational constants. Following [26], we fix the values of
the physical and model parameters as given below. To ease
readability, we only list the values and omit their measures.
p1 =
28
103 , p2 =
25
103 , p3 =
13
105 , p4 =
5
54 ,
GB = 110, Y B = 1.5, V L = 120.
(1)
We have now all ingredients to give the defining differ-
ential equations of the Bergman three-state minimal patient
control model. These equations are listed below:
G′(t) = −p1G(t)−X(t)(G(t) +GB) + h(t)
X ′(t) = −p2X(t) + p3Y (t)
Y ′(t) = −p4(Y (t) + Y B) + i(t)/V L
, (2)
where i(t) is the rational-valued control variable (input1) of
the model representing the exogenous insulin infusion rate
measured in mU/min, and h(t) is the rational-valued dis-
turbance (input2) of the model representing the exogenous
glucose infusion rate in mg/(dL ∗ min). We write G′(t)
(respectively, X ′(t) and Y ′(t)) to mean the partial derivative
of G(t) (respectively, of X(t) and Y (t)) wrt t.
In general, it is assumed that the state variable X(t) is a
so-called slow variable1, that is X ′[t] = 0 [19]. By making
use of this assumption, the defining equations of (2) are
reduced to the following model equations:
G′(t) = −p1G(t)−
p3
p2
Y (t)(G(t) +GB) + h(t)
Y ′(t) = −p4(Y (t) + Y B) + i(t)/V L
. (3)
In what follows, we use (3) as the defining equations of
the nonlinear diabetic control model under study.
C. Linearized Control Model
Note that (3) is a nonlinear differential equation system.
Therefore, the first step in analyzing this model is to trans-
form it into an equivalent, but linear system of differential
equations. The linearization is done in the equilibrium state
1to be precise, X′(t) can safely be approximated by 0
of system (3) denoted by X(0), Y (0), h(0), and i(0), where
X(0) = 0, Y (0) = 0, h(0) = 0, and i(0) = p4∗Y B∗V L =
16.667. As a result, we derive the following linearized model
of (3), written in matrix form:
x′(t) =
(
−p1 −
p3Y (0)
p2
−
(G(0)+GB)p3
p2
0 −p4
)
x(t)+(
1 0
0 1
V L
)
u(t)
y(t) =
(
1 0
0 1
)
x(t) +
(
0 0
0 0
)
u(t),
(4)
where x(t) denotes the states of the system given by (G(t),
Y (t)); y(t) represents the outputs of the system given by
(G(t), Y (t)); and u(t) denotes the inputs of the system given
by (i(t), h(t)).
Following the notations of a linear time invariant state-
space system [19], from (4) we get:
x′(t) = Ax(t) +Bu(t)
y(t) = Cx(t) +Du(t)
, (5)
where the following matrix equalities are satisfied: A =(
−p1 −
GBp3
p2
0 −p4
)
, B =
(
1 0
0 1
V L
)
, C =
(
1 0
0 1
)
and D =
(
0 0
0 0
)
.
As a result, we thus obtained a linear system (5) rep-
resenting the dynamics of the nonlinear system (3). By
reducing (3) to (5), the nonlinear Bergman model has thus
been linearized.
D. The minimax control method
In the study of the linearized Bergman three-state minimal
patient model, after linearization, one is interested to find
an optimal solution of (5). One way to find such an optimal
solution is by deploying the classical linear quadratic (LQ)
method [13], as follows. The LQ problem is defined to
find an optimal solution of (5) by using the quadratic cost
function:
J(u(t)) =
1
2
∫
∞
0
yT (t)Qy(t) + uT (t)Ru(t)dt, (6)
where R and Q are unknown constant square matrices
over the rationals, whose values effect the optimal solution
and can be arbitrarily chosen. This represents the major
disadvantage of the classical LQ method.
Therefore, the problem was extended by using modern
robust control theory. The extension or the generalized
version of the LQ method is called the minimax control
method [13]. The starting point of the minimax method is to
classify the the inputs of the system in two types, namely in
wanted inputs (e.g. control inputs u(t)) and unwanted inputs
(e.g. disturbances h(t), appeared to perturb the system).
Using this classification, the dynamics (5) of the linear
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model is changed by an explicit handling of the disturbance.
That is, (5) is changed into the following system describing
the dynamics of (4):
x′(t) = Ax(t) +Bu(t) + Lh(t)
y(t) = Cx(t) +Du(t)
, (7)
where L =
(
1 0
0 0
)
.
As a result, the quadratic cost function (6) of the LQ
method is changed to the following cost function of the
minimax method:
J(u(t)) =
1
2
∫
∞
0
yT (t)y(t)+uT (t) u(t)− γ2hT (t)h(t)dt, (8)
where γ > 0 is a positive rational constant. Note that,
unlike (6), in the case of using (8) we are left with only
one unknown rational constant, that is with γ. Hence, the
solution of u(t) in (8) is parameterized only by γ.
To find the optimal control means to compute the value of
γ, called the optimal value of γ, such that the value of (8) is
minimised. The optimal value of γ is computed by solving
the below given modified control algebraic Riccati equation
(MCARE) [13]:
PA+ATP + CTC − P
(
BBT −
1
γ2
LLT
)
P = 0, (9)
where P is a positive definite symmetric matrix, called the
solution of MCARE. The challenge of finding P comes
however with the fact that, in the general case, P is
a complex matrix. The elements of P are therefore not
guaranteed to be rationals, although in the study of (7) and
(8) we are interested to find rational solutions. Therefore,
when solving (9) our goal is to find an optimal rational
solution (see Section III) from which an optimum solution
of u(t) in (8) can be derived.
Note that in (8) the disturbance h(t) appears with negative
sign. Therefore, finding an optimum solution for u(t) that
minimizes the maximum cost of (8) is reduced to the
problem of finding the worst case disturbance value of h(t).
Hence, a worst case design problem appears that can be
written in the following minimax differential game:
max
h(t)
J (u(t), h(t)) → min
u(t)
J(u(t), h(t)). (10)
According to [13], the differential game (10) admits
a unique solution and its solution satisfies the following
saddle-point condition:
J (u∗(t), h(t)) ≤ J (u(t), h(t)) ≤ J (u(t), h∗(t)) , (11)
where u∗(t) is the optimal control solution for u(t), and
h∗(t) denotes the worst-case disturbance. In addition, the
optimal solutions for u(t) and h(t) satisfy the following
equations:
u∗(t) = −BTPx(t)
h∗(t) = 1
γ2
LTx(t)
. (12)
Minimizing the maximum cost of (8) requires thus com-
puting the matrix P such that (9) holds and P is rational
matrix. The challenge in deriving the optimal solutions (12)
is therefore to compute the unknown rational elements of P .
A standard approach for solving this challenge is to numer-
ically approximate P . However, numeric computations can
be expensive and crucially depend on the deployed preci-
sions for representing rational/complex values. To overcome
the burden of numeric representation, in what follows we
propose a symbolic approach to compute the matrix P as a
rational matrix satisfying (9).
III. PROBLEM SETTING AND STATEMENT: SOLVING
MCARE
Solving the linear model (7) of a diabetic control system
comes with the task of deriving the optimal solution of
the minimax differential game (10). To infer the optimal
solution of (10) reduces however to compute the rational
matrix solution of the MCARE system (9).
In what follows, let us focus our attention to solving (9),
more precisely, to compute the unknown coefficients of the
positive definite symmetric matrix P satisfying (9). To this
end, we consider P as follows:
P =
(
p11 p12
p12 p22
)
, (13)
where p11, p12, p22 are the unknown constants whose values
are to be determined. In the general case, p11, p12, p22
are complex constants. However, in finding the optimal
solution of (10) we are interested to derive p11, p12, p22
as rational constants. That is, we seek solutions to the
complex constants p11, p12, p22 such that the imaginary parts
of p11, p12, p22 can be approximated by zero, and therefore
minimized.
Substituting (13) in the left-hand-side of (9), the resulting
matrix is symmetric. Further, using (13) together with the
numeric values (1) of the physical and model parameters
in (9), we obtain the following system of equations:⎧⎪⎪⎪⎪⎨
⎪⎪⎪⎪⎩
7p11
125 +
p2
12
14400 −
p2
11
γ2
− 1 = 0
p12( 2604815 +p22)
14400 − p11
(
143
250 −
p12
γ2
)
= 0
143p12
125 +
(
5
27 +
p22
14400
)
p22 −
p2
12
γ2
− 1 = 0
(14)
Note that the resulting system of equations (14) is param-
eterized by γ and describes polynomial constraints over the
unknowns p11, p12, and p22. Let us denote by T the algebraic
field C[γ]. Then, (14) is a system of algebraic polynomials
with variables p11, p12, and p22, and with coefficients
from T. In other words, (14) describes polynomials from
T[p11, p12, p22]. In what follows, for a fixed positive γ ∈ Q,
we respectively denote by p∗11,γ , p
∗
12,γ , and p
∗
22,γ the values
of p11, p12, p22 such that (14) is satisfied.
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Any solution of (14) determines the elements of P in (9),
and hence yields a solution of (10). However, in order to
compute an optimal solution of (10), we need to ensure
that the solution of (14) is minimal, in the following sense.
Minimizing the solutions of (14) reduces to find the opti-
mal γ, denoted by γmin, such that the imaginary parts of
p∗11,γ , p
∗
12,γ , and p
∗
22,γ are minimal, that is (approximated
to) zero. The optimal value γmin of γ thus ensures that P
is a rational-valued matrix. Current approaches for deriving
γmin start from an arbitrarily chosen fixed γ and iteratively
approximate γmin by computing the numerical solution of
the multivariate polynomial (14) at every approximation step
of γmin. Namely, an interval halving iteration process is
computed to determine γmin. The halved intervals constrain
the sought positive rational value for γ and ensure a positive
definite matrix P .
However, recent advances [19] suggest that, instead of
minimizing the imaginary part of each element of P , it is
sufficient to minimize the imaginary part of only one of the
three unknowns of P . Therefore, in this paper, we propose
to seek the minimal γmin such that the imaginary part of
only one element of P , namely of p12, is minimal. Hence,
when solving (14) we also need to solve the following
minimization problem:
γmin = minγ
(
Im(p∗12,γ)
)
. (15)
Unlike existing methods, in this paper we thus reduce the
problem of minimizing the imaginary parts of solutions
of a multivariate polynomial system to the problem of
minimizing the imaginary part of the solution of a univariate
polynomial system.
Summarizing, our goal in this paper is to derive an optimal
solution of (10). For doing so, we need to solve (14) such
that (15) is also satisfied. Using the notation above, we
are therefore left with computing γmin and p
∗
11,γmin , p
∗
12,γmin ,
and p∗22,γmin . To this end, instead of using numeric approx-
imations for minimizing (15), we propose to first compute
p∗12,γ as a symbolic solution of (14) (see Section IV-B). For
doing so, we deploy the computation of Dixon resultants
(see Section IV-A). Next, γmin is derived by making use
of p∗12,γ and minimizing (15). We hence avoid solving nu-
merically the multivariate polynomial system resulting from
the minimization of (14), in every steps of the minimization
process.
IV. MCARE REDUCTION TO DIXON RESULTANTS
In Section III we showed that finding an optimal solution
of (14) corresponding to the MCARE system reduces to
minimizing (15). Minimizing (15) however comes with the
task of solving a system of polynomial equations. We
address this problem by deploying symbolic computation,
as follows.
One of the classical methods of solving a system of poly-
nomial equations is with so-called resultants. In our work,
for solving and minimizing the polynomial system (15)
constructed from the multivariate system (14), we make use
of Dixon resultants (see Section IV-A). By using Dixon
resultants, we then present our approach to derive optimal
solutions of (14) (see Section IV-B). Moreover, as the
Dixon resultants are relatively small in size, we argue that
our method is computationally less expensive than other
approaches using numeric techniques.
A. The Dixon Resultant
We begin by introducing the Dixon resultant for solving
a system of polynomial equations [27], [28]. The Dixon
resultant has various advantages over other resultant-based
elimination methods for solving polynomial equations. To
name a few, (i) the resulting matrix corresponding to the
polynomial system has a considerably smaller size, hence,
it is often easier to compute its determinant; (ii) a block of
variables can be eliminated in one calculation, instead of
using successive eliminations of variables. In the sequel, we
overview the main ingredients of Dixon resultants.
Dixon resultants of univariate polynomials. We first
recall Cayley’s formulation [29] for solving a system of
two polynomial equations. Consider two univariate poly-
nomials f(x), g(x) ∈ K[x], and we denote by degree(f),
degree(g) the degree of f and g, respectively. Let deg =
max(degree(f), degree(g)) and let a be a fresh new vari-
able. Then,
δ(x, a) = 1
x−a
det
(
f(x) g(x)
f(a) g(a)
)
= f(x)g(a)−f(a)g(x)
x−a
(16)
is a symmetric polynomial in variables x and a of degree
deg−1. The polynomial δ(x, a) ∈ K[x, a] is called the Dixon
polynomial of f and g. The common roots of f(x) and g(x)
are also roots of δ(x, a) for every value of a. Consequently,
at a common root, the coefficients of all powers ai in δ(x, a),
with i = 0, . . . , deg − 1, are functions of x and should
be zero. Using matrix notation, we thus have the following
homogeneous system in one variable:
M
⎛
⎜⎜⎜⎜⎜⎜⎝
1
x
.
.
.
xdeg−1
⎞
⎟⎟⎟⎟⎟⎟⎠
=
⎛
⎜⎜⎜⎜⎜⎜⎝
0
0
.
.
.
0
⎞
⎟⎟⎟⎟⎟⎟⎠
, (17)
the columns of the deg × deg matrix M consist of the
coefficients of ai. The matrix M is called the Dixon matrix
and its determinant D = det(M) is the Dixon resultant.
System (17) has nontrivial solutions if and only if D is zero.
Therefore, D = 0 is a necessary condition for the existence
of common roots of f and g.
Example 1: Let us consider the following example. We
take f(x) = x3−2x2−11x+12 and g(x) = x2+3x−4, and
57
D 
418 161 601 Γ8
167 961 600 000 000 000 000 000 000

2 924 207 Γ6 p12
167 961 600 000 000 000 000 000

143 286 143 Γ8 p12
10 497 600 000 000 000 000 000 000 000

20 449 Γ4 p122
447 897 600 000 000 000 000

14 080 956 461 Γ6 p122
195 910 410 240 000 000 000 000 000 000

32 650 536 864 803 Γ8 p122
61 222 003 200 000 000 000 000 000 000 000 000

143 Γ2 p123
2 687 385 600 000 000 000

737 530 079 Γ4 p123
1 959 104 102 400 000 000 000 000 000

94 090 852 999 Γ6 p123
61 222 003 200 000 000 000 000 000 000 000

143 286 143 Γ8 p123
151 165 440 000 000 000 000 000 000 000 000

p124
42 998 169 600 000 000

5 729 089 Γ2 p124
15 672 832 819 200 000 000 000 000

8 672 600 749 921 Γ4 p124
22 850 990 250 393 600 000 000 000 000 000 000

140 528 820 289 Γ6 p124
14 105 549 537 280 000 000 000 000 000 000 000

418 161 601 Γ8 p124
34 828 517 376 000 000 000 000 000 000 000 000
Figure 1. Dixon Resultant of MCARE (14), computed in Mathematica.
derive the Dixon polynomial δ(x, a) = 8− 4a− 4a2− 4x+
ax+3a2x− 4x2 +3ax2 + a2x2. By making the coefficient
of powers of a to be zero, (17) becomes:⎛
⎝ 8 −4 −4−4 1 3
−4 3 1
⎞
⎠
⎛
⎝ 1x
x2
⎞
⎠ =
⎛
⎝ 00
0
⎞
⎠ .
The Dixon matrix is thus M =
⎛
⎝ 8 −4 −4−4 1 3
−4 3 1
⎞
⎠ and its
determinant D is zero. Thus, f(x) and g(x) have common
root(s), namely x = 1.
Dixon resultants of multivariate polynomials. Cayley’s
formulation applies only to a system of univariate polyno-
mials. Dixon has therefore generalized Cayley’s approach
to systems of multi-variate polynomials, more precisely, to
a system of three polynomials with two variables, as follows.
Take the polynomials f(x, y), g(x, y), h(x, y) ∈ K[x, y], and
let a, b be fresh new variables. The polynomial δ(x, y, a, b) ∈
K[x, y, a, b] is then defined as:
δ(x, y, a, b) =
1
(x−a)(y−b)det
⎛
⎝ f(x, y) g(x, y) h(x, y)f(a, y) g(a, y) h(a, y)
f(a, b) g(a, b) h(a, b)
⎞
⎠ . (18)
The common roots of f(x, y), g(x, y) and h(x, y) are also
roots of δ(x, y, a, b) for every value of a and b. Setting
the power products aibj equal to zero, we again obtain a
homogenous system in x, y. The coefficient matrix M of this
homogenous system is the Dixon matrix, and its determinant
is the Dixon resultant D.
Similarly to the univariate case, Dixon proved that D = 0
is a necessary condition for the existence of common roots
of f, g, and h. Dixon’s method easily generalize to a system
of n + 1 polynomials of degree n with n variables, where
n ≥ 1. However, Dixon resultants can also be used to solve
a system of multivariate polynomials with n+1 variables of
degree n (or less). The idea is to consider the multivariate
polynomials with n + 1 variables and constant coefficients
as multivariate polynomials with n variables and coefficients
parameterized by one variable of the original polynomial
system. The example given below illustrates this idea.
Example 2: Let us consider the following example. Take
f(y, z) = x2+ y2− 1, g(y, z) = x2+ z2− 1, and h(y, z) =
y2 + z2 − 1. That is, f, g, h ∈ T[y, z], where T is K[x]. In
other words, the coefficients of f, g, h are parameterized by
x. We derive δ(y, z, a, b) = ab−2abx2+ by−2bx2y+az−
2ax2z+yz−2x2yz as the Dixon polynomial. By making the
coefficient of powers of ab to be zero, we obtain the Dixon
matrix M =
⎛
⎜⎜⎝
0 0 0 1− 2x2
0 0 1− 2x2 0
0 1− 2x2 0 0
1− 2x2 0 0 0
⎞
⎟⎟⎠.
The Dixon resultant is hence D = 1 − 8x2 + 24x4 −
32x6 +16x8. To ensure that f, g, h have common roots, we
impose the condition that D = 0. We are therefore left with
solving a univariate polynomial equation in x. Any value of
x satisfying D = 0, guarantees that f, g, h have roots, and in
addition, they have common roots. Note that substituting x
in f, g, h by its value computed from D = 0, the coefficients
of f, g, h parameterized by x become constants. Hence, in
solving the multi-variate polynomial system resulting from
f(y, z) = 0, g(y, z) = 0, h(y, z) = 0 one does not have to
derive also the value of x.
As shown in Example 2, Dixon’s generalized method
can be applied to polynomials with symbolic coefficients
(i.e. coefficients parameterized by variables). This property
of Dixon’s method allows the elimination of a block of
variables by one calculation of the Dixon resultants. As the
Dixon resultants are relatively small in size, we argue that
solving a system of multivariate polynomials using Dixon
resultants is a promising approach in various application
domains, in particular, in the study of the diabetic system
of glucose metabolism (Section IV-B).
B. Solving MCARE by Dixon Resultant Computations
Let us now reconsider the problem of finding an optimal
solution of the MCARE system given in (14). Solving (14)
means finding a common solution of the polynomial equa-
tions of (14). To this end, we propose to use the computation
of Dixon resultants. Note however that (14) is a system
of three polynomials with three variables and of degree
two. Hence, when solving (14) we proceed in a similar
manner as in Example 2, but also take into consideration
the minimization problem of (15). That is, we are interested
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Figure 2. p12 as function of γ, where p12 satisfies D = 0.
in solving (14), by also computing the value γ for which the
imaginary part of p12 is minimized (and therefore, p12 ∈ Q).
To this end, we apply Dixon resultant computation such that
we eliminate the variables p11, p22 and compute p12 as a
solution of the Dixon resultant. More precisely, we proceed
as follows.
We consider (14) as a system of three 2-degree univariate
polynomials in variables p11, p22, with coefficients parame-
terized by p12. We next introduce the fresh new variables a
and b, and compute the Dixon polynomial δ(p11, p22, a, b) as
given in (18). Setting further the power products aibj equal
to zero, a homogenous system in p12 is derived. The Dixon
resultant D computed for this univariate homogeneous sys-
tem yields a 4-degree univariate polynomial in p12, with
coefficients parameterized by γ, as listed in Figure 1.
As D = 0 is a necessary condition for the existence of
a solution of (14), we are left with solving the univariate
polynomial equation D = 0. Any value of p12 satisfying
D = 0 yields thus a solution of (14), however, not any
value of p12 gives an optimal solution of (10). In order to
ensure that an optimal solution of (10) is computed, we need
to solve the univariate polynomial equation D = 0 such
that (15) is also satisfied. That is, among the solutions of
D = 0 we compute γmin such that the imaginary part of
p12 is minimized (i.e. it is zero). Hence, the solution p
∗
12,γ
corresponding to γ = γmin not only satisfies the polynomial
equation D = 0, but also yields an optimal solution of (10).
To this end, by solving both D = 0 and (15), we obtain:
γmin = 17.1968.
Figure 2 shows how the imaginary part of p12 changes as
function of γ, where p12 is the (first) root of D = 0.
Using that γmin = 17.1968, we derive the value of p12 and
we replace γ by γmin in (14). This way, the numeric values
of p11, p12, p22 are obtained. As D = 0 yields four roots, we
obtain four different solutions for p11, p12, p22. Out of the
possible solutions for p11, p12, p22, we choose the solution
which makes matrix P to be a positive definite matrix. We
thus derive:
P =
(
299.512 −2034.94
−2034.94 14059.9
)
(19)
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Figure 3. Exogenous glucose infusion h(t) by meal.
as a solution of (9).
V. CASE STUDIES AND RESULTS
We report on three case studies using Dixon resultants in
the analysis of the presented blood-glucose problem (2). Our
case studies were carried out with the computer algebra sys-
tem Mathematica [24], by using the Mathematica package
of [23] for computing Dixon resultants.
In our case studies we were interested on the efficiency
and the robustness of our obtained control system solution,
given by (19). In what follows, (19) will be regarded as our
controller’s MCARE solution. By replacing the solution (19)
in the MCARE system (9), we derive the controller matrix
KLQR, called the gain matrix, as follows: KLQR =(
BT + 1
γmin
LT
)
P . Substituting matrixes by their concrete
values, we have:
KLQR =
(
1.01279 −6.88108
−16.9579 117.166
)
.
In our case studies we used as meal input the classical six
hour meal absorption profile modeled by [30] – see Figure 3.
When testing the performance of our controller, our case
studies reproduced the simulation scenarios used in [31].
Case study 1. In our first case study we turn back to the orig-
inal nonlinear model (2), even though the design of KLQR
was carried out on the reduced system (3). The glucose and
insulin concentrations of (2) are shown in Figures 4 and 5.
The results of our case study are in good agreement with
the previous results of [31], [19], and they emphasize the
use of our method. That is, using a methodology based on
Dixon resultants and therefore different than state-of-the-art
approaches, the same results can also be obtained. A more
important question appears though when the robustness of
our controller is investigated. The work of [31] shows that
when limiting the model parameter p1 to be zero, the system
is unable to regulate the glucose level on its own. Indeed,
when p1 = 0, the eigenvalues of the linearized model are
(−0.0925926,−0.025, 0), so the control system with p1 = 0
is unstable.
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Case study 2. In our second case study the constraint p1 = 0
was tested for the original nonlinear model (2). Our results
showed that our controller is able to control (2) even in this
case - see Figure 6. Moreover, the obtained results are better
then [19] and thus demonstrate the use of Dixon resultants.
However, it should be noted that the quality of the control
when p1 = 0 is not as precise as in the original case when
p1 = 0.028. This is due to the fact that, when p1 = 0, a
constant insulin infusion rate offset remains to compensate
the system error even at the equilibrium state.
Case study 3. Our third case study focused on the robustness
of the initial state of the nonlinear model (2). This question is
crucial as identifying the right model parameters is hard due
to, e.g., patient variability. Therefore, it is a nontrivial task
to determine where the simulation of (2) should start from.
Hence, a realistic sensor behavior performance is tested,
as follows. The insulin infusion rate is considered to be
nonnegative and its maximum value is limited. Figure 7
shows our results on simulating the nonlinear model (2) for
a negative deviation of the initial values of the model. In
the case of positive deviation of the initial values, we obtain
similar simulation results. Our results thus show that the
system performance can be stabilized fairly well even in the
situations when the initial values of the model are deviated
from their optimal values.
VI. CONCLUSIONS
We present the use of Dixon resultants in the study of the
Bergman three-state minimal patient model, in particular for
computing optimal solution of the modified control algebraic
Riccati equation of the model. Our approach benefits from
the small size of Dixon resultants and from the elimination
of block of variables using Dixon resultants. Moreover, the
derived solutions are symbolic and we thus avoid the burden
of successive numeric computations in inferring optimal
solutions. We give practical evidence of our method by
presenting three cases studies over glucose metabolism.
Further work includes applying our approach to nonlinear
models which are more complex than the Bergman three-
state minimal patient model.
ACKNOWLEDGMENT
We acknowledge funding from the Hungarian-Austrian
Aktion Foundation (project number 82o¨u11). Laura Kova´cs
0 200 400 600 800 1000
0
5
10
15
tmin
G
m
g
dl

Figure 6. G(t) in case of unstable
but controllable system, where p1
is 0).
0 200 400 600 800 1000
5
0
5
10
15
tmin
G
m
g
dl

Figure 7. G(t) in case of
negatively shifted initial values
and p1 = 0.
is supported by the FWF Hertha Firnberg Research grant
(T425-N23) and the FWF National Research Network RiSE
(S11410-N23). Levente Kova´cs is supported by the Ja´nos
Bolyai Research Scholarship of the Hungarian Academy of
Sciences. The work of Be´la Pala´ncz and Levente Kova´cs
is partially supported by the Hungarian National Scientific
Research Foundation (grants number OTKA 82066 and
CK80316). The research presented in this paper is partially
funded by the scientific program of the “Development of
quality-oriented and harmonized R+D+I strategy and func-
tional model at BME” project, supported by the New Hun-
gary Development Plan (project number TA´MOP-4.2.1/B-
09/1/KMR-2010-0002).
REFERENCES
[1] S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global
Prevalence of Diabetes - Estimates for the Year 2000 and
Projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–
1053, 2004.
[2] J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, “Global Estimates
of the Prevalence of Diabetes for 2010 and 2030,” Diabetes
Research and Clinical Practice, vol. 87, pp. 4–14, 2010.
[3] A. Fonyo´ and E. Ligeti, Physiology (in Hungarian), 3rd ed.
Medicina, Budapest, 2008.
[4] C. Cobelli, C. D. Man, G. Sparacino, L. Magni, G. de Nico-
lao, and B. Kovatchev, “Diabetes: Models, Signals, and Con-
trol (Methodological Review),” IEEE Reviews in Biomedical
Engineering, vol. 2, pp. 54–96, 2009.
[5] R. Harvey, Y. Wang, B. Grossman, M. Percival, W. Bevier,
D. Finan, H. Zisser, D. Seborg, L. Jovanovic, F. Doyle,
and E. Dassau, “Quest for the Artificial Pancreas,” IEEE
Engineering in Medicine and Biology, vol. 29, no. 2, pp. 53–
62, 2010.
[6] F. Chee and F. Tyrone, Closed-loop Control of Blood Glucose,
ser. LNCS. Springer-Verlag, Berlin, 2007, vol. 368.
[7] B. N. Bergman, Y. Z. Ider, C. R. Bowden, and C. Cobelli,
“Quantitive Estimation of Insulin Sensitivity,” American Jour-
nal of Physiology, vol. 236, pp. 667–677, 1979.
[8] C. D. Man, R. Rizza, and C. Cobelli, “Meal Simulation
Model of the Glucose-Insulin System,” IEEE Transactions
on Biomedical Engineering, vol. 54, no. 10, pp. 1740–1749,
2007.
60
[9] L. Magni, D. M. Raimondo, C. D. Man, G. D. Nicolao,
B. Kovatchev, and C. Cobelli, “Model Predictive Control
of Glucose Concentration in Type I Diabetic Patients: An
In Silico Trial,” Biomedical Signal Processing and Control,
vol. 4, no. 4, pp. 338–346, 2009.
[10] R. Hovorka, V. Canonico, L. J. Chassin, U. Haueter,
M. Massi-Benedetti, M. O. Federici, T. R. Pieber, H. C.
Schaller, L. Schaupp, T. Vering, and M. Wilinska, “Nonlin-
ear Model Predictive Control of Glucose Concentration in
Subjects with Type 1 Diabetes,” Physiological measurement,
vol. 25, pp. 905–920, 2004.
[11] R. S. Parker, F. J. D. III, J. H. Ward, and N. A. Peppas, “Ro-
bust H∞ Glucose Control in Diabetes Using a Physiological
Model,” AIChE Journal, vol. 46, no. 12, pp. 2537–2549, 2000.
[12] J. T. Sorensen, “A Physiologic Model of Glucose Metabolism
in Man and its Use to Design and Assess Improved Insulin
Therapies for Diabetes,” Ph.D. dissertation, Dept. of Chemi-
cal Eng. Massachusetts Institute of Technology, Cambridge,
1985.
[13] K. Zhou, Robust and Optimal Control. Prentice Hall, New
Jersey, 1996.
[14] L. Kovacs, “New principles and adequte control methods
for insulin optimization in case of type i diabetes mellitus,”
Ph.D. dissertation, Budapest University of Technology and
Economics, Hungary, 2007.
[15] L. Kovacs, B. Benyo, J. Bokor, and Z. Benyo, “Induced
L2-norm minimization of glucose-insulin system for type i
diabetic patients,” Comp Meth Prog Biomed, Special issue on
Glucose Modelling, vol. 102(2), pp. 105–118, 2011.
[16] A. Isidori, Nonlinear Control Systems, 3rd ed. Springer,
Berlin, 1995.
[17] L. Kova´cs, P. Szalay, B. Benyo´, and J. Chase, “Optimal
Tight Glycaemic Control Supported by Differential Geometric
Methods,” in Proc. of 5th European Conference of the Inter-
national Federation for Medical and Biological Engineering,
2011, pp. 351–354.
[18] H. Gong, P. Zuliani, and E. M. Clarke, “Model Checking
of a Diabetes-Cancer Model,” in Proc. of CMLS, 2011, pp.
234–243.
[19] L. Kova´cs and B. Pala´ncz, “Glucose-Insulin Control of Type 1
Diabetic Patients in H2/H∞ Space Via Computer Algebra,”
in Proc. of AB, ser. LNCS, vol. 4545, 2007, pp. 95–109.
[20] B. Buchberger, “Symbolic computation: Computer algebra
and logic,” in Frontiers of Combining Systems, ser. Applied
Logic Series. Kluwer Academic Publishers, 1996, vol. 3,
pp. 193–219.
[21] E. M. Clarke, O. Grumberg, and D. A. Peled, Model Check-
ing. MITPress, 1999.
[22] B. Buchberger, “Gro¨bner-Bases: An Algorithmic Method
in Polynomial Ideal Theory,” in Multidimensional Systems
Theory - Progress, Directions and Open Problems in Mul-
tidimensional Systems, 1985, pp. 184–232.
[23] G. Nakos and R. Williams, “Elimination with the Dixon
Resultant,” Mathematica in Education and Research, vol. 6,
no. 3, pp. 11–21, 1997.
[24] S. Wolfram, The Mathematica Book. Version 5.0. Wolfram
Media, 2003.
[25] F. J. Ayres, Schaum’s Outline of Theory and Problems of
Matrices. New York: Schaum, 1962.
[26] S. M. Furler, E. W. Kraegen, R. H. Smallwood, and D. J.
Chisolm, “Blood glucose control by intermittent loop closure
in the basal mode: Computer simulation studies with a
diabetic model,” Diabetes Care, vol. 8, pp. 553–561, 1985.
[27] A. Dixon, “The Eliminant of Three Quantics in Two Inde-
pendent Variables,” London Mathematical Society, vol. 6, pp.
468–478, 1908.
[28] A. D. Chtcherba, D. Kapur, and M. Minimair, “Cayley-Dixon
Resultant Matrices of Multi-univariate Composed Polynomi-
als,” in Proc. of CASC, 2005, pp. 125–137.
[29] A. Cayley, “On the Theory of Elimination,” Cambridge and
Dublin Mathematical Journal, vol. III, pp. 210–270, 1865.
[30] E. D. Lehmann and T. A. Deutsch, “A physiological model
of glucose-insulin interaction in Type1 diabetes mellitus,”
Journal of Biomedical Engineering, vol. 14, pp. 235–242,
1992.
[31] N. Hernjak and F. J. Doyle III, “Glucose control design using
nonlinearity assessment techniques,” AIChE Journal, vol. 51,
no. 2, pp. 544–554, 2005.
61
